Skip to main content
Premium Trial:

Request an Annual Quote

Eric Meyers, John Hallinan, John McCarthy, Eric Lachenmeier

Premium

3rd Millennium of Cambridge, Mass., has promoted Eric Meyers from vice president of marketing and business development to the newly created position of chief operating officer. In this role, Meyers will oversee the company’s new business development, recruitment, partnering, and marketing efforts, in addition to supporting 3rd Millennium’s “aggressive growth initiatives in the coming year,” according to a company statement.

 

AnVil of Burlington, Mass., has hired John Hallinan as CFO and John McCarthy as director of discovery informatics.

Hallinan was previously CFO at Boston-based 3D application provider Animation Technologies. Prior to that, he was the CFO of life science and chemical software firm CambridgeSoft. McCarthy most recently served as director of bioinformatics at Cellomics of Pittsburgh, Pa.

 

Eric Lachenmeier, former vice president of technology development at Incyte Genomics, has been tapped as the new director of business development at San Diego, Calif.-based biochip company Aviva Biosciences. Lachenmeier, who was also the founder and president of Allegro Biosciences and an R&D project leader and engineer at Lynx Therapeutics and Applied Biosystems, will be responsible for Aviva’s fundraising efforts.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.